Thursday, November 5, 2026

Nuveen California Municipal Value Fund, Inc. And 3 Other Stocks Have Very High Payout Ratio

ViaNews Editorial Team

January 4, 2021

Nuveen California Municipal Value Fund, Inc. And 3 Other Stocks Have Very High Payout Ratio

We have congregated information concerning stocks with the highest payout ratio so far. The payout ratio in itself isn't a guarantee of good investment but it's an indicator of whether dividends are being paid and how the company chooses to issue them.

When investigating a potential investment, the dividend payout ratio is a good statistic to know and anything around 60 percent is considered high.

1. KKR & Co. L.P.

30.41% Payout Ratio

According to Morningstar, Inc., the next dividend payment is on Nov 12, 2020, the estimated forward annual dividend rate is 0.54 and the estimated forward annual dividend yield is 1.37%.

KKR & Co. L.P.'s sales growth this year is expected to be 5.2% and 18% for next year.

Year-on-year quarterly revenue growth grew by 349.6%, now sitting on 4.72B for the twelve trailing months.

KKR & Co. L.P.'s sales growth is 1.2% for the ongoing ongoing quarter and 14.9% for the next. The company's growth estimates for the present quarter and the next is negative 6.8% and 14.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.42%.

Volatility

KKR & Co. L.P.'s last day, last week, and last month's average volatility was a negative 0.13%, a negative 0.14%, and a positive 0.09%, respectively.

KKR & Co. L.P.'s last day, last week, and last month's high and low average amplitude percentage was 1.66%, 1.39%, and 1.79%, respectively.

KKR & Co. L.P.'s Stock Yearly Top and Bottom Value

KKR & Co. L.P.'s stock is valued at $39.43 at 07:23 EST, below its 52-week high of $40.71 and way higher than its 52-week low of $15.55.

KKR & Co. L.P.'s Moving Average

KKR & Co. L.P.'s value is higher than its 50-day moving average of $38.93 and above its 200-day moving average of $35.85.

2. PIMCO California Municipal Income Fund

140% Payout Ratio

PIMCO California Municipal Income Fund is a closed ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC.

As claimed by Morningstar, Inc., the next dividend payment is on Dec 15, 2020, the estimated forward annual dividend rate is 0.78 and the estimated forward annual dividend yield is 4.35%.

PIMCO California Municipal Income Fund's sales growth this year is anticipated to be negative 0% and a negative 0% for next year.

Year-on-year quarterly revenue growth declined by 12.4%, now sitting on 19.26M for the twelve trailing months.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.6%.

Volatility

PIMCO California Municipal Income Fund's last day, last week, and last month's average volatility was a negative 0.50%, a negative 0.30%, and a positive 0.09%, respectively.

PIMCO California Municipal Income Fund's last day, last week, and last month's high and low average amplitude percentage was 1.52%, 1.33%, and 1.22%, respectively.

PIMCO California Municipal Income Fund's Stock Yearly Top and Bottom Value

PIMCO California Municipal Income Fund's stock is valued at $17.86 at 07:23 EST, way under its 52-week high of $20.08 and way above its 52-week low of $12.55.

PIMCO California Municipal Income Fund's Moving Average

PIMCO California Municipal Income Fund's worth is higher than its 50-day moving average of $17.79 and higher than its 200-day moving average of $17.37.

3. Nuveen California Municipal Value Fund, Inc.

113.1% Payout Ratio

Nuveen California Municipal Value Fund, Inc. is a closed-ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC.

According to Morningstar, Inc., the next dividend payment is on Dec 13, 2020, the estimated forward annual dividend rate is 0.32 and the estimated forward annual dividend yield is 2.96%.

Nuveen California Municipal Value Fund, Inc.'s sales growth this year is expected to be negative 0% and a negative 0% for next year.

Year-on-year quarterly revenue growth declined by 4.5%, now sitting on 10.89M for the twelve trailing months.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 2.63%.

Volatility

Nuveen California Municipal Value Fund, Inc.'s last day, last week, and last month's average volatility was 2.18%, 0.26%, and 0.16%, respectively.

Nuveen California Municipal Value Fund, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 2.46%, 2.17%, and 1.26%, respectively.

Nuveen California Municipal Value Fund, Inc.'s Stock Yearly Top and Bottom Value

Nuveen California Municipal Value Fund, Inc.'s stock is valued at $10.91 at 07:23 EST, below its 52-week high of $10.98 and way higher than its 52-week low of $8.74.

Nuveen California Municipal Value Fund, Inc.'s Moving Average

Nuveen California Municipal Value Fund, Inc.'s value is above its 50-day moving average of $10.45 and above its 200-day moving average of $10.48.

4. Lear Corporation

84.44% Payout Ratio

Lear Corporation designs, develops, engineers, manufactures, assembles, and supplies automotive seating, and electrical distribution systems and related components for automotive original equipment manufacturers in North America, Europe, Africa, Asia, South America, and internationally.

As stated by Morningstar, Inc., the next dividend payment is on Dec 8, 2020, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 0.63%.

Lear Corporation's sales growth this year is expected to be negative 15.5% and 19.1% for next year.

Year-on-year quarterly revenue growth grew by 1.6%, now sitting on 16.62B for the twelve trailing months.

Lear Corporation's sales growth is 2.8% for the ongoing present quarter and 12% for the next. The company's growth estimates for the present quarter and the next is 26.9% and 62.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.48%.

Volatility

Lear Corporation's last day, last week, and last month's average volatility was a negative 0.25%, a positive 0.04%, and a positive 0.39%, respectively.

Lear Corporation's last day, last week, and last month's high and low average amplitude percentage was 1.83%, 1.95%, and 2.48%, respectively.

Lear Corporation's Stock Yearly Top and Bottom Value

Lear Corporation's stock is valued at $158.83 at 07:23 EST, under its 52-week high of $165.67 and way higher than its 52-week low of $63.20.

Lear Corporation's Moving Average

Lear Corporation's worth is higher than its 50-day moving average of $150.62 and way above its 200-day moving average of $125.27.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com